View more on these topics

Product matters

I am only in favour of structured products linked to one index, preferably the FTSE 100, as in the Prudential income & growth plan.

In the current climate, the five-year term of this plan is preferable to three-year products as this gives more time to iron out the peaks and troughs.

The income level at 8 per cent a year or 0.62 per cent a month and growth of 42 per cent on maturity are slightly lower than rivals but this is compensated by some of the advantages on offer – headline rate should not be the only consideration.

For instance, Prudential will also pay interest from the date that it receives a client&#39s investment to the investing date at a rate comparable with bank deposit accounts – not a lot but better than nothing. The interest is added to the initial investment at the time the funds are invested.

While the level of income or growth is fixed, return of capital is not guaranteed.

This means that an investor opting for income would, effectively, be using his own capital to support the level of income if the index underperformed so much that it breached the safety net.

The first barrier of this safety net is if the FTSE falls by below 75 per cent of its level at January 13, 2003 during its “observation period” from January 13, 2004 to November 28, 2007. This is not particularly generous and means the second barrier (falling below 60 per cent) comes in at a fairly early stage. If either is breached, there would be loss of capital. A breach of the second barrier could mean 100 per cent loss of capital.

Colin Jackson is a director of Baronworth Investment Services


Threadneedle eyes up health stocks

THREADNEEDLE INVESTMENTS THREADNEEDLE GLOBAL HEALTHCARE FUND Type: Oeic Aim: Growth by investing in pharmaceutical companies, biotechnology, healthcare providers, medical supply companies and producers of advanced medical devices Minimum investment: Lump sum £2,000 Investment split: Pharmaceuticals 55.5%, healthcare 14%, biotechnology 9.5%, medical technology 7%, medical supplies 8.5%, cash 5.5% Isa link: Yes Pep transfers: Yes Charges: […]

UBS fund scours the US

UBS Asset Management has established its fourth UK retail fund, the US equity fund.The fund aims for capital growth by investing in between 80 and 90 US stocks. Around 65 per cent of the portfolio will consist of large caps and 35 per cent will go in to mid caps.Tom Digenan, a Chicago-based executive director […]

UBS Global Asset Management – US Equity Fund

Thursday, 3 October 2002 Type: Oeic Aim: Growth by investing in US equities Minimum investment: Lump sum £1,000, monthly £50 Investment split: US large-cap companies 65%, US mid-cap companies 35% Yield: None Isa link: Yes Pep transfers: Yes Charges: Class A shares &#45 initial 4%, annual 1.5%, class B shares &#45 annual 0.9% Commission: Initial […]

Politicians to blame for misselling, says Pickering

Politicians and civil servants must shoulder some of the blame for pension misselling as they created the environment that allowed it to happen, according to pension review chief Alan Pickering.Speaking at the Chartered Insurance Institute annual conference in Birmingham last week, Pickering said that by not allowing concurrency during the years when pension misselling occurred, […]


News and expert analysis straight to your inbox

Sign up


    Leave a comment


    Why register with Money Marketing ?

    Providing trusted insight for professional advisers.  Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm